The findings that NF90 promotes VEGF-A expression and angiogenesis of cervical cancer cells in vitro prompted us to test whether NF90 deficiency may affect ectopic tumor growth and angiogenesis in tumor xenograft assays. This evidence concerns the gene VEGFA and cervical carcinoma.